AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

NovoCure Ltd Director's Dealing 2021

Feb 13, 2021

31949_dirs_2021-02-12_5f165f48-e690-4a0c-95bc-186ef3ca054c.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2021-02-05

Reporting Person: Scannell Timothy J (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	75	Direct